Holen Sie sich die Stockscreener-App
2.84
3.65%
0.10
Handel nachbörslich:
2.84
Schlusskurs vom Vortag:
$2.74
Offen:
$2.89
24-Stunden-Volumen:
35,406
Relative Volume:
3.62
Marktkapitalisierung:
$148.71M
Einnahmen:
$18.85M
Nettoeinkommen (Verlust:
$-119.67M
KGV:
-1.078
EPS:
-2.6346
Netto-Cashflow:
$-89.09M
1W Leistung:
+13.15%
1M Leistung:
+30.88%
6M Leistung:
+19.33%
1J Leistung:
-13.15%
1-Tages-Spanne:
$2.74
$2.98
1-Wochen-Bereich:
$2.52
$2.98
52-Wochen-Spanne:
$1.53
$4.50
Inventiva Adr Stock (IVA) Company Profile
Vergleichen Sie IVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
2.84 | 148.71M | 18.85M | -119.67M | -89.09M | -2.6346 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-21 | Eingeleitet | TD Cowen | Buy |
| 2024-11-12 | Eingeleitet | UBS | Neutral |
| 2023-10-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-31 | Eingeleitet | ROTH MKM | Buy |
| 2023-05-19 | Hochstufung | Societe Generale | Sell → Buy |
| 2023-03-17 | Eingeleitet | Stifel | Buy |
| 2022-11-15 | Herabstufung | Societe Generale | Buy → Sell |
| 2021-03-08 | Herabstufung | Societe Generale | Buy → Sell |
| 2020-08-05 | Eingeleitet | ROTH Capital | Buy |
| 2020-08-04 | Eingeleitet | Guggenheim | Buy |
| 2020-08-04 | Eingeleitet | Stifel | Buy |
Alle ansehen
Inventiva Adr Aktie (IVA) Neueste Nachrichten
Inventiva et Hepalys Pharma, Inc. annoncent le lancement du programme de développement clinique de lanifibranor au Japon avec l'inclusion du premier participant dans l'étude de Phase 1 - GlobeNewswire Inc.
Top 10 Best Indian Companies In Smart Grids Solutions 2025 - Inventiva
Inventiva (IVA) Loses -17.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN
Inventiva ADR (IVA) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Stifel reiterates Buy rating on Inventiva stock, cites financing deal - Investing.com
Why Are Criminals Still in Power? 151 Lawmakers with Charges of Crimes Against Women Continue to Hold Office! Is This the End of Integrity in Indian Politics? - Inventiva
Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA) - Yahoo Finance
NOTA, No Votes and Unopposed Nominations: The Grey Areas of the Indian Election Process Explained - Inventiva
Will Election Commission Make Sure That Elections In 2024 Will Be Completely Fair? - Inventiva
Is SBI's Demand For Extra Time To Disclose Details Of Electoral Bonds 1 Attempt To Hide The Doings And Doers Of ‘Great Political Chanda’? - Inventiva
symbol__ Stock Quote Price and Forecast - CNN
National Parties Declare Assets Worth Rs 8,829 Crore In 2021-22: Report - Inventiva
Explosive Showdown: Rahul Yadav-Led 4B Networks Clash with Info Edge in High-Stakes Arbitration Battle - Inventiva
The Indian Chief Ministers Are A Bunch Of Crorepatis While The Average Middle-Class Indian Tax Payer Is Struggling To Survive - Inventiva
Top 10 Best Handicraft Companies In USA 2023 - Inventiva
Top 20 Best Hardware & Networking Company In India 2023 - Inventiva
Top 10 Best Law Firms In India 2023. - Inventiva
Top 10 Best LegalTech companies in India 2023 - Inventiva
An Interesting Telecom Startup Announced Funding Of INR 30 Crore - Inventiva
TCS, Infosys, Wipro Hire Over 1 Lakh Employees This Fiscal. Know Details - Inventiva
8 US equities have commenced trading on the NSE IFSC in GIFT City; All information about how to start trading through IFSC and should you put money in US stocks? - Inventiva
Innovation And Technology Revolutionizing The Legal Landscape In India 2022 - Inventiva
India Has Its First Most Awaited International Arbitration Centre In Hyderabad In 2021. - Inventiva
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance
Finanzdaten der Inventiva Adr-Aktie (IVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):